Pre-transplant sensitization and its effect on heart transplant rejection and survival outcomes
Transplant Immunology · 2025
DOI: 10.1016/j.trim.2025.102264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Immunology, 2025. Verfasst von Kyung-Hwa Shin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Pusan National University School of medicine, Yangsan, Republic of Korea; Department of Laboratory Medicine and Bi…. Hauptthemen laut MEDLINE: Heart Transplantation, Graft Rejection, Isoantibodies, T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Sensitization of heart transplant (HT) recipients increases the risk of rejection. Assessment of sensitization using a calculated panel reactive antibody (cPRA) is crucial for evaluating transplant compatibility and predicting outcomes. This study investigated the impact of cPRA and pre-existing and de novo Human Leukocyte Antigen (HLA)-donor-specific antibodies (DSAs) on HT outcomes and aimed to identify recipients at a high risk of rejection. METHODS: This retrospective study included 121 adult recipients of HT from a single institution (2014-2023). cPRA values, flow cytometric crossmatches (FCXM), and DSAs were analyzed for their associations with antibody-mediated rejection (AMR) and T cell-mediated rejection (TCMR). RESULTS: Among the 121 HT recipients, 51.2 % experienced TCMR and 7.4 % experienced AMR. cPRA (I) ≥ 50 % was significantly associated with AMR, pre-existing DSA (pDSA), and positive FCXM. pDSA was present in 16.5 % of HT recipients and correlated with AMR but not mortality. De novo DSAs frequently emerged in 38 % of the recipients following TCMR episodes. Higher cPRA (I) levels correlated with increased rejection risk and shorter AMR-free survival. CONCLUSIONS: High cPRA (≥50 %) significantly predicted the risk of AMR and correlated with pDSA and positive FCXM results. Pre-transplant cPRA assessment is crucial for identifying high-risk recipients and optimizing management strategies to improve HT outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Pusan National University School of medicine, Yangsan, Republic of Korea; Department of Laboratory Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan…
- Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea; Department of…
- Department of Cardiovascular Surgery, Pusan National University School of Medicine, Yangsan, Republic of Korea; Department of Cardiovascular Surgery and Research Institute for Convergence of Biomedical Science and Techn…
- Department of Laboratory Medicine, Pusan National University School of medicine, Yangsan, Republic of Korea; Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan Nat…
Zitieren
APA
Shin, K. H., Lee, S. Y., Ju, M. H., & Lee, H. J. (2025). Pre-transplant sensitization and its effect on heart transplant rejection and survival outcomes. Transplant Immunology. https://doi.org/10.1016/j.trim.2025.102264
Vancouver
Shin KH, Lee SY, Ju MH, Lee HJ. Pre-transplant sensitization and its effect on heart transplant rejection and survival outcomes. Transplant Immunology. 2025. doi:10.1016/j.trim.2025.102264
BibTeX
@article{Shin2025,
author = {Shin, Kyung-Hwa and Lee, Soo Yong and Ju, Min Ho and Lee, Hyun-Ji},
title = {Pre-transplant sensitization and its effect on heart transplant rejection and survival outcomes},
journal = {Transplant Immunology},
year = {2025},
doi = {10.1016/j.trim.2025.102264}
}
EUVIMED